Cochrane Reviews See Exercise As Beneficial for Patients and Survivors

A pair of Cochrane Reviews have been published, throwing their support behind the benefits of exercise for cancer patients and cancer survivors. Perhaps they will put an end to the mixed signals sent of late by doctors and researchers alike regarding the benefits of exercise in cancer care.

"Together, these reviews suggest that exercise may provide quality of life benefits for people who are undergoing or have undergone treatment for cancer,"

In the first review, Cochrane researchers examined 40 different trials involving 3,694 cancer survivors randomized to exercise or to a control group. Exercise could have meant strength training, resistance training, walking, cycling or something like Tai Chi or yoga.

They found that exercise positively impacted overall health-related quality of life. It also positively impacted specific quality-of-life domains, such as body image and self-esteem. It boosted social confidence while diminishing anxiety, pain and fatigue.

The second study examined 56 trials involving 4,826 cancer patients in which patients were randomized to exercise or to a control group. Findings were similar to the cancer survivor group: it improved overall health-related quality of life, as well as physical functioning while diminishing fatigue.

Nonetheless, researchers urged that these findings be taken as reason to explore the topic more deeply. All cancer patients are urged to discuss these findings with their doctor to determine if exercise might be right for them.

Source: MedPage Today

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap